News

CATGLOBIN concludes the newborn screening for sickle cell disease pilot study in Catalonia

Results have led to the imminent implementation of universal neonatal screening for haemoglobinopathies in the early detection official program

November 25, 2014

Catglobin

CATGLOBIN, Catalan network for the diagnosis and monitoring of haemoglobinopathies and thalassemia, is a project funded by Marató TV3 and integrated by a multidisciplinary team of 56 health professionals belonging to 15 hospitals distributed all over the region of Catalonia. Their main objective is to ensure a correct diagnosis, prevention and clinical management of sickle cell anemia, thalassemia syndromes and other haemoglobinopathies associated with chronic anemia. Furthermore, since the beginning of the network in 2009, the project offers to partner institutions the possibility of carrying out the genetic study of patients through the web platform project (www.catglobin.cat).


Taking into account that mortality associated with sickle cell syndrome decreases from 8% to 1% through detection in the neonatal period and the start of appropriate preventive measures, in addition with the fact that Catalonia presents the highest flow of immigration potentially carrier of  sickle cell trait in Spain, CATGLOBIN  in collaboration with the Public Health Agency of Catalonia,  launched a universal newborn screening for sickle cell disease pilot study in March 2013 for the participating centers. The program came to an end in March 2014 with more than 26,000 newborns screened (40% of the total population born) allowing the prevalence estimation for sickle cell disease in 1 per 3909 newborns, and 1 per 144 in case of sickle cell trait.


Beyond the lifetime of the pilot study, sickle cell disease has been recently included as one of the seven diseases that constitute the endocrine-metabolic neonatal screening program within the common services portfolio of National Healthcare System.


The implementation of systematic and universal neonatal screening for haemoglobinopathies in the early detection official program of Catalonia has been imminent and will start in the beginning of 2015. Report is available in Public Health Agency of Catalonia website.

 

 

 

Copyright © 2002 - 2017 Enerca

Co-funded by the Health Programme of the European Union.